Literature DB >> 20723821

Contemporary management of patients with type 1 diabetes.

Sanjeev N Mehta1, Joseph I Wolfsdorf.   

Abstract

The current standard of care for patients with type 1 diabetes (T1D) employs a system of intensive diabetes management aimed at near-normal glycemia, which reduces the risk of micro- and macrovascular complications. Optimal management is an ongoing process based on a patient-centered collaboration with a primary care clinician and a multidisciplinary diabetes team that provides diabetes management, including education and psychosocial support. Intensive diabetes therapy attempts to mimic physiologic insulin replacement. Over the past 15 years, there has been widespread use of multiple-dose insulin regimens using a variety of insulin analogs, administered either by injection or insulin pump therapy, together with medical nutrition therapy, frequent self-monitoring of blood glucose and, more recently, continuous logo glucose monitoring. It is now possible to achieve previously unattainable levels of glycemic control with less risk of severe hypoglycemia, and yet only a minority of patients achieves target hemoglobin A1c values. This review discusses contemporary management of T1D with a focus on health outcomes. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20723821     DOI: 10.1016/j.ecl.2010.05.002

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  9 in total

1.  Self-adjustment of insulin dose using graphically depicted self-monitoring of blood glucose measurements in patients with type 1 diabetes mellitus.

Authors:  Andreas Reichel; Hannes Rietzsch; Barbara Ludwig; Katrin Röthig; Annette Moritz; Stefan R Bornstein
Journal:  J Diabetes Sci Technol       Date:  2013-01-01

Review 2.  Management of diabetes mellitus: is the pump mightier than the pen?

Authors:  John C Pickup
Journal:  Nat Rev Endocrinol       Date:  2012-02-28       Impact factor: 43.330

Review 3.  Management of type 1 diabetes in children and adolescents.

Authors:  Vandana Jain
Journal:  Indian J Pediatr       Date:  2013-10-11       Impact factor: 1.967

Review 4.  Developmental changes in the roles of patients and families in type 1 diabetes management.

Authors:  Jessica T Markowitz; Katharine C Garvey; Lori M B Laffel
Journal:  Curr Diabetes Rev       Date:  2015

5.  Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology.

Authors:  Wendy C Bevier; Serena M Fuller; Ryan P Fuller; Richard R Rubin; Eyal Dassau; Francis J Doyle; Lois Jovanovič; Howard C Zisser
Journal:  Diabetes Technol Ther       Date:  2014-05-08       Impact factor: 6.118

6.  Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes.

Authors:  Ronnie Aronson; Peter A Gottlieb; Jens S Christiansen; Thomas W Donner; Emanuele Bosi; Bruce W Bode; Paolo Pozzilli
Journal:  Diabetes Care       Date:  2014-07-10       Impact factor: 19.112

7.  Intensively managed young children with type 1 diabetes consume high-fat, low-fiber diets similar to age-matched controls.

Authors:  Sanjeev N Mehta; Lisa K Volkening; Nicolle Quinn; Lori M B Laffel
Journal:  Nutr Res       Date:  2014-04-21       Impact factor: 3.315

8.  Characteristics of children with type 1 diabetes and persistent suboptimal glycemic control.

Authors:  Hyuntae Kim; Angelo Elmi; Celia L Henderson; Fran R Cogen; Paul B Kaplowitz
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-06

9.  Association between Glycemic Control and Clinic Attendance in Emerging Adults with Type 1 Diabetes: A Tertiary Center Experience.

Authors:  Eldad Fisher; Liora Lazar; Shlomit Shalitin; Michal Yackobovitch-Gavan; Liat de Vries; Tal Oron; Ariel Tenenbaum; Moshe Phillip; Yael Lebenthal
Journal:  J Diabetes Res       Date:  2018-07-09       Impact factor: 4.011

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.